Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$9.34M |
| 2 |
US Bancorp
USB
|
+$5.68M |
| 3 |
International Flavors & Fragrances
IFF
|
+$3.82M |
| 4 |
Biogen
BIIB
|
+$1.31M |
| 5 |
AT&T
T
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$8.94M |
| 2 |
Compass Minerals
CMP
|
+$8.23M |
| 3 |
Lam Research
LRCX
|
+$2.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.69M |
| 5 |
Amazon
AMZN
|
+$2.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.7% |
| 2 | Healthcare | 17.67% |
| 3 | Communication Services | 16% |
| 4 | Financials | 12.57% |
| 5 | Consumer Staples | 11.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stryker
SYK
$126B
| $219K | 0.08% |
800
| – | – |
|
52
iShares Russell Mid-Cap ETF
IWR
$57.7B
| $180K | 0.07% |
2,601
-73
| -3% | -$5.33K |
|
53
iShares Core S&P 500 ETF
IVV
$893B
| $171K | 0.07% |
398
| – | – |
|
|
54
Compass Minerals
CMP
$1.09B
| – | – |
-242,010
| Closed | -$8.23M |
|
|
55
Enterprise Products Partners
EPD
$82.1B
| – | – |
-339,224
| Closed | -$8.94M |
|
56
iShares US Technology ETF
IYW
$24.9B
| – | – |
-2,250
| Closed | -$245K |
|
57
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| – | – |
-6,563
| Closed | -$982K |
|
Similar funds
Mark Hillman's Q3 2023 Portfolio in Review
As of Q3 2023, Mark Hillman held 57 positions worth $260M, down 8.3% from $283M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Mark Hillman's Q3 2023 filing shows 2 new, 13 increased, 34 reduced and 4 closed positions. Its largest new stake was Baxter International: 219,248 shares worth $8.27M. The largest sale was Enterprise Products Partners, an estimated $8.94M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Communication Services.
- Mark Hillman's largest Q3 2023 buy was Baxter International: 219,248 shares worth $8.27M.
- Mark Hillman added most to International Flavors & Fragrances in Q3 2023, an estimated $3.82M increase.
- Mark Hillman's biggest Q3 2023 reduction was Lam Research, cutting an estimated $2.9M.
- Mark Hillman fully exited Enterprise Products Partners in Q3 2023, selling an estimated $8.94M.
- Mark Hillman's ten largest holdings make up 33% of its $260M portfolio in Q3 2023.
- Mark Hillman opened 2 new positions and closed 4 in Q3 2023.
- Mark Hillman's portfolio value fell 8.3% quarter-over-quarter to $260M.
Based on Hillman Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.